Gilead Sciences Stock Target Price and Analyst Consensus

GILD Stock  USD 73.01  0.60  0.83%   
The current analyst and expert consensus on Gilead Sciences is Buy with 7 buy recommendations. The current projected Gilead Sciences target price consensus is 85.47, with 31 analyst opinions. The most common way Gilead Sciences analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Gilead Sciences executives, vendors, and/or customers. Gilead Sciences buy-or-sell recommendation module provides average expert sentiment on the projected Gilead Sciences target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Gilead Sciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
Lowest Forecast
77.78
Highest Forecast
94.87
Target Price
85.47
The current year's Gross Profit is expected to grow to about 28.5 B. The current year's Pretax Profit Margin is expected to grow to 0.27. At present, Gilead Sciences' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 11.8 B, whereas Cash is forecasted to decline to about 3.8 B.
  
It's important to approach Gilead Sciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Gilead Sciences Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Gilead target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Gilead Sciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   31  Buy
Most Gilead analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Gilead stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Gilead Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Gilead Sciences Target Price Projection

Gilead Sciences' current and average target prices are 73.01 and 85.47, respectively. The current price of Gilead Sciences is the price at which Gilead Sciences is currently trading. On the other hand, Gilead Sciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Gilead Sciences Market Quote on 28th of March 2024

Low Price72.55Odds
High Price73.06Odds

73.01

Target Price

Analyst Consensus On Gilead Sciences Target Price

Low Estimate77.78Odds
High Estimate94.87Odds

85.47

Historical Lowest Forecast  77.78 Target Price  85.47 Highest Forecast  94.87
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Gilead Sciences and the information provided on this page.

Gilead Sciences Analyst Ratings

Gilead Sciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Gilead Sciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Gilead Sciences' financials, market performance, and future outlook by experienced professionals. Gilead Sciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Gilead Sciences price targets

Gilead Sciences' stock target price is an estimate of its future price, usually made by analysts. Using Gilead Sciences' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Gilead Sciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Gilead Sciences' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Gilead Sciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Gilead Sciences is a key component of Gilead Sciences valuation and have some predictive power on the future returns of a Gilead Sciences.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gilead Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
71.2773.0174.75
Details
Intrinsic
Valuation
LowRealHigh
68.3570.0980.31
Details
Naive
Forecast
LowNextHigh
69.7271.4673.20
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.211.581.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Gilead Sciences. Your research has to be compared to or analyzed against Gilead Sciences' peers to derive any actionable benefits. When done correctly, Gilead Sciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Gilead Sciences.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Blockchain Idea
Blockchain
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Momentum Idea
Momentum
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Tech Growth Idea
Tech Growth
Invested over 100 shares
FinTech Idea
FinTech
Invested over 70 shares
Millennials Best Idea
Millennials Best
Invested over 30 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested a lot of shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
IT Idea
IT
Invested few shares
Information Technology ETFs Idea
Information Technology ETFs
Invested few shares
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Macroaxis Advice on Gilead Sciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
The data published in Gilead Sciences' official financial statements usually reflect Gilead Sciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Gilead Sciences. For example, before you start analyzing numbers published by Gilead accountants, it's critical to develop an understanding of what Gilead Sciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Gilead Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gilead Sciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Gilead Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Gilead Sciences. Please utilize our Beneish M Score to check the likelihood of Gilead Sciences' management manipulating its earnings.